Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference98 articles.
1. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes, 2015. A patient-centered approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of diabetes. Diab Care. 2015;(38):140–9.
2. Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA, et al. Consensus statement by the American Association of Clinical Endocrinologists and the American College of Endocrinology on the comprehensive type 2 diabetes management algorithm—2016 executive summary. Endocr Pract. 2016;(22):84–113.
3. Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med. 2007;356:2457–71.
4. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm109026.htm (Avandia restrictions)
5. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm376516.htm (Avandia restriction lifted)
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献